Back to top

Bioanalytical Systems Loss Widens in Q1, Revenues Fall

Read MoreHide Full Article

Bioanalytical Systems Inc. reported first-quarter fiscal 2016 loss of 6 cents per share which was wider than the figure reported in the previous quarter.

Quarter Details

Revenues decreased 16.3% year over year to $48.9 million primarily owing to a 41.9% decline in Products segment revenues.

Most of the decline at the Product segment rose from decreased sales of Bioanalytical’s Culex automated in-vivo sampling systems and analytical instruments.

Service segment revenues also declined 7.8% to $4.5 million primarily due to lower laboratory service revenue from fewer bioequivalence studies.

Gross profits declined 48.3% year over year to $9.8 million primarily due to lower revenues.

Selling expenses, Research and Development (R&D) and General and Administrative (G&A) expenses declined 8.6%, 17.8% and 15.1% year over year, respectively.

Decline in G&A expenses was primarily due to declining commission and deductions made on a growing rental income of $1.59 million.

This resulted in a 14.1% year-over-year decline in operating expenses. Another reason that caused the decline was lower utilization of outsourced engineering services.

Bioanalytical incurred an operating loss of $5.29 million compared to its operating income of $1.42 million in the year-ago quarter primarily due to decreased revenues.

In first-quarter fiscal 2016, EBITDA was a negative $1.71 million compared to a positive $5.05 million recorded in the year-ago quarter.

Key Picks

Well placed stocks in the same space include ABIOMED Inc. (ABMD - Free Report) , CryoLife Inc. (CRY - Free Report) and Edwards Lifesciences Corp. (EW - Free Report) . All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


ABIOMED, Inc. (ABMD) - free report >>

Edwards Lifesciences Corporation (EW) - free report >>

CryoLife, Inc. (CRY) - free report >>

More from Zacks Analyst Blog

You May Like